HIV inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9309237
APP PUB NO 20140377219A1
SERIAL NO

14241329

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Chemical compounds that inhibit retroviruses are presented herein. More particularly, this disclosure provides small molecule compounds that inhibit infection with, or treat infection caused by, human immunodeficiency viruses.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES6701 ROCKLEDGE DRIVE SUITE 700 MS 7788 OFFICE OF TECHNOLOGY TRANSFER NATIONAL INSTITUTES OF HEALTH BETHESDA MD 20892

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Curreli, Francesca New York, US 14 76
Debnath, Asim Kumar New York, US 28 188
Kwon, Young Do Bethesda, US 65 1270
Kwong, Peter D Bethesda, US 48 271

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 12, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00